APPLIED GENETIC TECH CORP has a total of 15 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2012. It filed its patents most often in Japan, China and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are JAIN ARJUN, SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD and FERRUMAX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 9 | |
#2 | China | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Ye Guo-Jie | 5 |
#2 | Peter Armstrong Thompson | 3 |
#3 | John W Blankenship | 3 |
#4 | Jeffrey A Ledbetter | 2 |
#5 | Lioudmila Tchistiakova | 2 |
#6 | Maximillian T Follettie | 2 |
#7 | Alwin Schuler | 2 |
#8 | Robert Bader | 2 |
#9 | Laura Sue Grosmaire | 2 |
#10 | Valerie Calabro | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017070491A1 | Ophthalmic formulations | |
CN105764531A | Promoters, expression cassettes, vectors, kits, and methods for the threatment of achromatopsia and other diseases |